Immediate Impact

1 by Nobel laureates 2 from Science/Nature 52 standout
Sub-graph 1 of 23

Citing Papers

The present and future of bispecific antibodies for cancer therapy
2024 Standout
Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death
2024 Standout
2 intermediate papers

Works of Chengming Liu being referenced

The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity
2019

Author Peers

Author Last Decade Papers Cites
Chengming Liu 632 464 351 80 1.3k
Meng Su 1070 307 197 71 1.7k
Toshiaki Ohara 616 578 261 110 1.6k
Jingjing Yu 762 347 201 81 1.5k
Min Jiao 669 326 183 78 1.3k
Bo Hong 784 553 155 79 1.6k
Yiwei Wang 874 244 168 69 1.5k
Yao Yuan 828 488 181 66 1.5k
Qiong Ma 880 272 241 73 1.6k
Yun‐Hee Kim 801 346 128 67 1.4k
Ziyi Yang 511 246 226 107 1.1k

All Works

Loading papers...

Rankless by CCL
2026